Aruna Bio Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Aruna Bio General Information
Description
Developer of a neural exosome platform designed to prepare medicine for the treatment of neural diseases. The company's platform harnesses the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders, enabling drug manufacturers to prepare the drug for stroke, traumatic brain, and spinal cord injuries.
Contact Information
Website
www.arunabio.comCorporate Office
- 184 Collins Industrial Boulevard
- Suite A
- Athens, GA 30601
- United States
Corporate Office
- 184 Collins Industrial Boulevard
- Suite A
- Athens, GA 30601
- United States
Aruna Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Secondary Transaction - Private | 01-Mar-2026 | Completed | Clinical Trials - Phase 1 | |||
| 17. Grant | 01-Jun-2022 | Completed | Clinical Trials - Phase 1 | |||
| 16. Later Stage VC | 14-Apr-2021 | Completed | Clinical Trials - Phase 1 | |||
| 15. Debt - PPP | 09-Apr-2020 | Completed | Clinical Trials - Phase 1 | |||
| 14. Grant | 18-Sep-2019 | Completed | Clinical Trials - Phase 1 | |||
| 13. Later Stage VC | 24-Jul-2019 | Completed | Clinical Trials - Phase 1 | |||
| 12. Later Stage VC | 19-Jul-2018 | Completed | Clinical Trials - Phase 1 | |||
| 11. Grant | 01-Sep-2017 | Completed | Clinical Trials - Phase 1 | |||
| 10. Later Stage VC | 28-Apr-2017 | $3.73M | $3.9M | Completed | Clinical Trials - Phase 1 | |
| 9. Grant | 01-Jan-2017 | $725K | $164K | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aruna Bio Comparisons
Industry
Financing
Details
Aruna Bio Competitors (59)
One of Aruna Bio’s 59 competitors is Coave Therapeutics, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Coave Therapeutics | Venture Capital-Backed | Paris, France | ||||
| T3D Therapeutics | Venture Capital-Backed | Durham, NC | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Fauna Bio | Venture Capital-Backed | Emeryville, CA | ||||
| Aquinnah | Venture Capital-Backed | Cambridge, MA |
Aruna Bio Patents
Aruna Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260130947-A1 | Extracellular vesicles for treatment of amyotrophic lateral sclerosis | Pending | 07-Jul-2023 | ||
| WO-2025012776-A1 | Extracellular vesicles for treatment of amyotrophic lateral sclerosis | Inactive | 07-Jul-2023 | ||
| AU-2021264512-A1 | Binding agents and uses thereof for central nervous system delivery | Pending | 27-Apr-2020 | ||
| CA-3176495-A1 | Binding agents and uses thereof for central nervous system delivery | Pending | 27-Apr-2020 | ||
| EP-4142737-A1 | Binding agents and uses thereof for central nervous system delivery | Pending | 27-Apr-2020 | A61K47/6901 |
Aruna Bio Signals
Aruna Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Irrus Investments | Angel Group | Minority | ||
| National Institutes of Neurological Disorders and Stroke | Government | |||
| Eshelman Ventures | Venture Capital | Minority | ||
| Evolution VC Partners | Venture Capital | Minority | ||
| GRA Venture Fund | Venture Capital | Minority |
Aruna Bio FAQs
-
When was Aruna Bio founded?
Aruna Bio was founded in 2003.
-
Where is Aruna Bio headquartered?
Aruna Bio is headquartered in Athens, GA.
-
What is the size of Aruna Bio?
Aruna Bio has 27 total employees.
-
What industry is Aruna Bio in?
Aruna Bio’s primary industry is Drug Delivery.
-
Is Aruna Bio a private or public company?
Aruna Bio is a Private company.
-
What is Aruna Bio’s current revenue?
The current revenue for Aruna Bio is .
-
How much funding has Aruna Bio raised over time?
Aruna Bio has raised $33.4M.
-
Who are Aruna Bio’s investors?
Irrus Investments, National Institutes of Neurological Disorders and Stroke, Eshelman Ventures, Evolution VC Partners, and GRA Venture Fund are 5 of 7 investors who have invested in Aruna Bio.
-
Who are Aruna Bio’s competitors?
Coave Therapeutics, T3D Therapeutics, Cristal Therapeutics, Fauna Bio, and Aquinnah are some of the 59 competitors of Aruna Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process